NYSE: ACR
Acres Commercial Realty Corp Stock

$17.53+0.57 (+3.36%)
Updated Apr 22, 2025
ACR Price
$17.53
Fair Value Price
N/A
Market Cap
$130.71M
52 Week Low
$12.33
52 Week High
$23.81
P/E
14.73x
P/B
0.3x
P/S
1.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$83.49M
Earnings
$29.27M
Gross Margin
88.7%
Operating Margin
35.21%
Profit Margin
10.9%
Debt to Equity
3.26
Operating Cash Flow
$19M
Beta
0.87
Next Earnings
Apr 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ACR Overview

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ACR's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Mortgage REIT

Industry Rating
D
ACR
Ranked
#6 of 39

Top Ranked Stocks in Industry

View Top Mortgage REIT Stocks

Be the first to know about important ACR news, forecast changes, insider trades & much more!

ACR News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ACR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACR is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACR is good value based on its earnings relative to its share price (14.73x), compared to the US market average (28.14x)
P/E vs Market Valuation
ACR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ACR due diligence checks available for Premium users.

Valuation

ACR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
14.73x
Industry
8.59x
Market
28.14x
ACR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ACR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ACR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.3x
Industry
0.71x
ACR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACR's financial health

Profit margin

Revenue
$21.4M
Net Income
$9.5M
Profit Margin
19.1%
ACR's Earnings (EBIT) of $29.39M... subscribe to Premium to read more.
Interest Coverage Financials
ACR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.9B
Liabilities
$1.4B
Debt to equity
3.26
ACR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ACR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$757.0k
Investing
$124.5M
Financing
-$138.6M
ACR's operating cash flow ($19.39M)... subscribe to Premium to read more.
Debt Coverage Financials

ACR vs Mortgage REIT Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ACRC$130.71M+3.36%14.73x0.30x
SUNSC$131.26M+3.38%9.68x1.15x
RPTC$128.70M+6.27%-1.18x0.52x
LFTC$139.14M+2.31%7.82x0.59x
CHMIC$87.92M+6.11%39.71x0.38x

Acres Commercial Realty Stock FAQ

What is Acres Commercial Realty's quote symbol?

(NYSE: ACR) Acres Commercial Realty trades on the NYSE under the ticker symbol ACR. Acres Commercial Realty stock quotes can also be displayed as NYSE: ACR.

If you're new to stock investing, here's how to buy Acres Commercial Realty stock.

What is the 52 week high and low for Acres Commercial Realty (NYSE: ACR)?

(NYSE: ACR) Acres Commercial Realty's 52-week high was $23.81, and its 52-week low was $12.33. It is currently -26.38% from its 52-week high and 42.17% from its 52-week low.

How much is Acres Commercial Realty stock worth today?

(NYSE: ACR) Acres Commercial Realty currently has 7,456,150 outstanding shares. With Acres Commercial Realty stock trading at $17.53 per share, the total value of Acres Commercial Realty stock (market capitalization) is $130.71M.

Acres Commercial Realty stock was originally listed at a price of $168.00 in Feb 7, 2006. If you had invested in Acres Commercial Realty stock at $168.00, your return over the last 19 years would have been -89.57%, for an annualized return of -11.21% (not including any dividends or dividend reinvestments).

How much is Acres Commercial Realty's stock price per share?

(NYSE: ACR) Acres Commercial Realty stock price per share is $17.53 today (as of Apr 22, 2025).

What is Acres Commercial Realty's Market Cap?

(NYSE: ACR) Acres Commercial Realty's market cap is $130.71M, as of Apr 24, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acres Commercial Realty's market cap is calculated by multiplying ACR's current stock price of $17.53 by ACR's total outstanding shares of 7,456,150.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.